THQ
abrdn Healthcare Opportunities FundMarquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management | Q4 2025 | Q2 2026 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at abrdn Healthcare Opportunities Fund. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jul 18, 2024 — the most recent Form 4 on file — not from today.
- Form 40001104659-24-080800Jul 18, 2024
- Form 40001104659-24-046550Apr 12, 2024
- Form 40001104659-24-001274Jan 4, 2024
- Form 40001104659-24-000361Jan 2, 2024
- Form 40001104659-22-037467Mar 24, 2022
- Form 40001104659-22-008201Jan 27, 2022
- Form 40001104659-21-030170Mar 1, 2021
- Form 40001104659-20-107791Sep 23, 2020
- Form 40001104659-20-034867Mar 17, 2020
- Form 40001104659-18-063921Oct 25, 2018
- Form 40001104659-18-062504Oct 17, 2018
- Form 40001104659-18-061572Oct 11, 2018
- Form 40001104659-18-061368Oct 10, 2018
- Form 40001728564-18-000007Jan 29, 2018
- Form 40001104659-14-084860Dec 4, 2014
Fundamentals
XBRL · abrdn Healthcare Opportunities FundNot enough XBRL history to plot. abrdn Healthcare Opportunities Fundhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for abrdn Healthcare Opportunities Fund — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementApr 7, 2026
- DEF 14AProxy statementApr 14, 2025
- DEF 14AProxy statementApr 22, 2024
- 8-KFORM 8-KSep 12, 2023
- DEF 14AProxy statementJul 10, 2023
- DEF 14AProxy statementApr 11, 2023
- DEF 14AProxy statementApr 12, 2022
- DEF 14AProxy statementApr 13, 2021
- DEF 14AProxy statementApr 14, 2020
- DEF 14AProxy statementApr 15, 2019
- SC 13G/AMSSB EXITFeb 12, 2019
- DEF 14AProxy statementApr 18, 2018
- SC 13G/AMS AMENDMENTFeb 13, 2018
- DEF 14APRE 14AApr 18, 2017
- SC 13G/AMSSB YE AMENDMENTFeb 13, 2017
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q4 2025 | Q2 2026 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.